Research led by Jack Tseng, PhD, assistant professor
of pathology and anatomical sciences, found that a wolf-sized
otter that lived about 6 million years ago may have been a dominant
predator in its time.
New clues to non-alcoholic fatty liver disease (NAFLD), which
affects nearly all obese adults and a rising percentage of obese
children, have been reported in a paper by senior author Susan
S. Baker MD, PhD.
Four studies focused on improving our understanding of the human
genome and microbiome have been awarded funding through the third
round of research pilots supported by the Community of
Excellence in Genome, Environment and Microbiome (GEM).
A new book co-edited by Mulchand S. Patel, PhD, SUNY
Distinguished Professor of biochemistry, discusses how the
path to obesity may start before birth or during infancy and how an
individual’s metabolism can be permanently reprogrammed by
overfeeding early in life.
A newly patented technology developed as a collaboration in the
departments of Biomedical Engineering, Orthopaedics, and
Microbiology and Immunology is at the heart of an Office of Naval
Research (ONR) grant focused on preventing and treating orthopaedic
A global study led by Paresh Dandona, MD, PhD, found a majority
of patients with Type 1 diabetes who were treated with
dapagliflozin, a Type 2 diabetes medicine, had a significant
decline in their blood sugar levels.
Daniel J. Kosman, PhD, SUNY Distinguished Professor of
biochemistry, has been awarded a five-year, $1.96 million grant
that may lead to advances in understanding the progression of
Researchers in the Department of Medicine have published a study
that identifies a new way to predict which patients may be at a
higher risk for heart failure after undergoing Transcatheter Aortic
Valve Implantation (TAVR).
Umesh Sharma, MD, PhD, assistant professor of medicine, has
received a five-year, $1 million grant from the National Institutes
of Health (NIH) to study galectin-3, a protein involved in heart
Researchers in the Department of Pharmacology and
Toxicology have developed and successfully tested a method for
determining whether promising new multiple sclerosis (MS)
treatments in mice could be effective in humans.